2021 annual financial data
Celldex Therapeutics 2021 Operating margin
Direct answer
Operating margin was -1,531.78%.
Operating income was -71,243,000 USD and net income was -70,511,000 USD.
Operating cash flow was -60,909,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,651,000 USD
- Operating income
- -71,243,000 USD
- Net income
- -70,511,000 USD
- Operating cash flow
- -60,909,000 USD